$PGEN
PRECIGEN, INC. Stock $pgen

$pgen Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000135609024000017 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$953.0K	$717.0K
YoY Change	-30.94%	-59.42%
Cost Of Revenue	$1.009M	$1.014M
YoY Change	-34.48%	-40.25%
Gross Profit	-$56.00K	-$297.0K
YoY Change	-65.0%	-524.29%
Gross Profit Margin	-5.88%	-41.42%
Selling, General & Admin	$9.836M	$10.31M
YoY Change	6.91%	10.63%
% of Gross Profit
Research & Development	$11.37M	$15.69M
YoY Change	-1.81%	32.16%
% of Gross Profit
Depreciation & Amortization	$356.0K	$388.0K
YoY Change	-17.97%	-18.32%
% of Gross Profit
Operating Expenses	$21.21M	$26.00M
YoY Change	2.05%	22.69%
Operating Profit	-$21.26M	-$26.30M
YoY Change	1.54%	24.51%
Interest Expense	$281.0K	$317.0K
YoY Change	-67.33%	-54.19%
% of Operating Profit
Other Income/Expense, Net	-$2.985M	$43.00K
YoY Change	-1166.07%	16.22%
Pretax Income	-$23.97M	-$60.48M
YoY Change	21.03%	196.71%
Income Tax	$12.00K	-$1.689M
% Of Pretax Income
Net Earnings	-$23.98M	-$58.79M
YoY Change	21.13%	189.34%
Net Earnings / Revenue	-2516.05%	-8199.72%
Basic Earnings Per Share	-$0.09	-$0.23
Diluted Earnings Per Share	-$0.09	-$0.23
COMMON SHARES
Basic Shares Outstanding	252.8M shares	252.4M shares
Diluted Shares Outstanding	275.9M shares	252.4M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.63M	$19.54M
YoY Change	-61.2%	-77.91%
Cash & Equivalents	$24.73M	$9.345M
Short-Term Investments	$3.906M	$10.19M
Other Short-Term Assets	$5.153M	$3.163M
YoY Change	1.04%	13.29%
Inventory
Prepaid Expenses
Receivables	$479.0K	$511.0K
Other Receivables	$250.0K	$505.0K
Total Short-Term Assets	$34.51M	$23.72M
YoY Change	-62.88%	-77.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.54M	$13.45M
YoY Change	90.27%	104.61%
Goodwill	$24.92M	$24.92M
YoY Change	-32.46%	-32.59%
Intangibles	$4.773M	$5.091M
YoY Change	-88.19%	-88.06%
Long-Term Investments
YoY Change
Other Assets	$425.0K	$435.0K
YoY Change	-46.68%	-54.16%
Total Long-Term Assets	$48.96M	$49.45M
YoY Change	-49.89%	-51.47%
TOTAL ASSETS
Total Short-Term Assets	$34.51M	$23.72M
Total Long-Term Assets	$48.96M	$49.45M
Total Assets	$83.47M	$73.16M
YoY Change	-56.22%	-64.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.320M	$4.846M
YoY Change	83.75%	93.07%
Accrued Expenses	$16.49M	$17.80M
YoY Change	-45.04%	-36.99%
Deferred Revenue	$407.0K	$378.0K
YoY Change	-20.04%	2420.0%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$21.22M	$23.02M
YoY Change	-35.46%	-25.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$6.793M	$6.890M
YoY Change	-15.09%	-17.61%
Total Long-Term Liabilities	$6.793M	$6.890M
YoY Change	-15.09%	-17.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.22M	$23.02M
Total Long-Term Liabilities	$6.793M	$6.890M
Total Liabilities	$28.10M	$29.99M
YoY Change	-34.67%	-27.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.071B	-$2.047B
YoY Change	7.23%	7.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$55.38M	$43.17M
YoY Change
Total Liabilities & Shareholders Equity	$83.47M	$73.16M
YoY Change	-56.22%	-64.75%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$23.98M	-$58.79M
YoY Change	21.13%	189.34%
Depreciation, Depletion And Amortization	$356.0K	$388.0K
YoY Change	-17.97%	-18.32%
Cash From Operating Activities	-$22.73M	-$23.11M
YoY Change	33.72%	46.54%
INVESTING ACTIVITIES
Capital Expenditures	$882.0K	$2.323M
YoY Change	283.48%	2200.0%
Acquisitions
YoY Change
Other Investing Activities	$6.535M	$17.28M
YoY Change	-39.27%	-26.8%
Cash From Investing Activities	$5.653M	$14.95M
YoY Change	-46.32%	-36.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.13M	52.00K
YoY Change		-100.36%
NET CHANGE
Cash From Operating Activities	-22.73M	-23.11M
Cash From Investing Activities	5.653M	14.95M
Cash From Financing Activities	32.13M	52.00K
Net Change In Cash	15.05M	-8.100M
YoY Change	-332.57%	18.25%
FREE CASH FLOW
Cash From Operating Activities	-$22.73M	-$23.11M
Capital Expenditures	$882.0K	$2.323M
Free Cash Flow	-$23.61M	-$25.43M
YoY Change	37.06%	60.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-58792000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	166210000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	118498000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1718000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-113000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	240307403	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	240307403	shares
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58904000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20138000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83492000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42083000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	97019000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1964000	usd
CY2024Q2	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	52000	usd
CY2024Q2	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3039000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-112000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	43170000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	184133000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2188000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20319000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	181000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4545000	usd
	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	52000	usd
	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3039000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	528000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-82530000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-962000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	43170000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	126259000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5320000	usd
	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	0	usd
	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3361000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	545000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	72808000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43053000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	970000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	166210000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-82530000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43053000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3191000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3404000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	40000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	32915000	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	60000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	570000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	721000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4545000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5320000	usd
	pgen	Shares Issued During Period Value Issued For Services SharesIssuedDuringPeriodValueIssuedForServices	528000	usd
	pgen	Shares Issued During Period Value Issued For Services SharesIssuedDuringPeriodValueIssuedForServices	545000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	60000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-391000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	376000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-490000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	226000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1158000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2274000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-55000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-83000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3178000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1536000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1468000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1804000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-235000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1740000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-131000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-10000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	303000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	229000	usd
	pgen	Increase Decrease Settlement And Identification Accruals IncreaseDecreaseSettlementAndIdentificationAccruals	-1862000	usd
	pgen	Increase Decrease Settlement And Identification Accruals IncreaseDecreaseSettlementAndIdentificationAccruals	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37197000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34156000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	51664000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	128563000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	97335000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	101852000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6674000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	255000	usd
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	3000	usd
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	61000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	39000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26905000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72808000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	120000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	43219000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	52000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29589000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-95000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-172000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1760000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31644000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7848000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48596000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9608000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16952000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1156000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	4000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	pgen	Accrued Compensation Paid In Equity Awards AccruedCompensationPaidInEquityAwards	3039000	usd
	pgen	Accrued Compensation Paid In Equity Awards AccruedCompensationPaidInEquityAwards	3361000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1171000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	19000	usd
	pgen	Sale Of Assets Included In Accounts Receivable SaleOfAssetsIncludedInAccountsReceivable	57000	usd
	pgen	Sale Of Assets Included In Accounts Receivable SaleOfAssetsIncludedInAccountsReceivable	0	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9345000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7578000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	263000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	270000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9608000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7848000	usd
CY2024Q2	pgen	Number Of Wholly Owned Operating Subsidiaries NumberOfWhollyOwnedOperatingSubsidiaries	2	subsidiary
	us-gaap	Net Income Loss NetIncomeLoss	-82530000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37197000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2047001000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	19536000	usd
CY2024Q2	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	16895000	usd
CY2023Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	17800000	usd
	pgen	Highly Liquid Investment Maximum Maturity Period HighlyLiquidInvestmentMaximumMaturityPeriod	P3M
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28190478	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24202403	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2196000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2327000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	378000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	509000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2196000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2327000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	10207000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	15000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	10191000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	10191000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	55310000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	103000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	136000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	55277000	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	10191000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	55277000	usd
CY2024Q2	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2023Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2024Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2629000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2629000	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	379000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	530000	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	16628000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18576000	usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4475000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4380000	usd
CY2024Q2	pgen	Breeding And Production Animals Gross BreedingAndProductionAnimalsGross	83000	usd
CY2023Q4	pgen	Breeding And Production Animals Gross BreedingAndProductionAnimalsGross	79000	usd
CY2024Q2	pgen	Computer Hardware And Software ComputerHardwareAndSoftware	3213000	usd
CY2023Q4	pgen	Computer Hardware And Software ComputerHardwareAndSoftware	3459000	usd
CY2024Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8109000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1577000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35680000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31394000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22229000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24283000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13451000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7111000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	388000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	475000	usd
	us-gaap	Depreciation Depreciation	768000	usd
	us-gaap	Depreciation Depreciation	981000	usd
CY2024Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	110000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	110000	usd
CY2024Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	488000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	488000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	26612000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-64000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	24918000	usd
CY2024Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	26503000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	24873000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-32317000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1208000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1218000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2423000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2423000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1689000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-65000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1718000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-120000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	43962640	shares
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72808000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	43962640	shares
CY2018Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	7479431	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1964000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2188000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4545000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5320000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22057340	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.90
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M19D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6852634	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.41
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	36458	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	611750	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.51
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	857997	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	16.23
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27403769	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.36
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M19D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15595522	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
	pgen	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	609000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	617000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1218000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1232000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	22000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	35000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	30000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	92000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	86000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	184000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	206000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	723000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	713000	usd
	us-gaap	Lease Cost LeaseCost	1437000	usd
	us-gaap	Lease Cost LeaseCost	1468000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1090000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1611000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1473000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1303000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1260000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1295000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	552000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8584000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2243000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6341000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1269000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5072000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6341000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M20D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.114
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.112
	us-gaap	Operating Lease Payments OperatingLeasePayments	1144000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1022000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	572000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	373000	usd
CY2024Q2	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	0	usd
CY2023Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	0	usd
CY2024Q2	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-28057000	usd
CY2023Q2	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-17337000	usd
	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-52077000	usd
	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-38559000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60481000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20384000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-84248000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43173000	usd
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001356090-24-000017-index-headers.html	Edgar Link	pending
0001356090-24-000017-index.html	Edgar Link	pending
0001356090-24-000017.txt	Edgar Link	pending
0001356090-24-000017-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pgen-20240630.htm	Edgar Link	pending
pgen-20240630.xsd	Edgar Link	pending
pgen-20240630xexx311.htm	Edgar Link	pending
pgen-20240630xexx312.htm	Edgar Link	pending
pgen-20240630xexx321.htm	Edgar Link	pending
pgen-20240630xexx322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
pgen-20240630_cal.xml	Edgar Link	unprocessable
pgen-20240630_def.xml	Edgar Link	unprocessable
pgen-20240630_lab.xml	Edgar Link	unprocessable
pgen-20240630_pre.xml	Edgar Link	unprocessable
pgen-20240630_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PGEN
PRECIGEN, INC. Stock $pgen

2024 Q3 Form 10-Q Financial Statement

#000135609024000017 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN PRECIGEN, INC. Stock $pgen

2024 Q3 Form 10-Q Financial Statement

#000135609024000017 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN
PRECIGEN, INC. Stock $pgen